Nutanix, Inc. Class A NTNX 深 滬
等待開盤 01-29 09:30:00 美东时间
41.78
+0.540
+1.31%
華盛通- 最 高42.55
- 今 開41.65
- 成交量 381.89万股
- 最 低 41.42
- 昨 收 41.24
- 總市值 112.39亿
- 52周最高 83.36
- 市盈率 靜 64.15
- 換手率 1.42%
- 52周最低 41.15
- 委 比 -65.29%
- 總股本 2.69亿
- 歷史最高 83.36
- 量 比 0.88
- 振 幅 2.74%
- 歷史最低 11.31
- 每 手 1
- 風險率 9.72%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Top 3 Tech Stocks That Are Set To Fly This Month
The most oversold stocks in the information technology sector presents an oppor...
01-23 19:05
美股大行评级 | 阿斯麦、美光科技、SanDisk获大行上调目标价；美国银行、富国银行绩后遭多家机构下调目标价
今日重点评级关注：Benchmark：维持TNL Mediagene"投机性买入"评级，目标价从3.5美元升至14美元；康托·菲茨杰拉德：维持Eupraxia Pharmaceuticals"超配"评级，目标价从11美元升至19美元
01-16 10:04
Boeing To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-15 21:01
Barclays Downgrades Nutanix to Equal-Weight, Lowers Price Target to $53
Barclays analyst Tim Long downgrades Nutanix (NASDAQ:NTNX) from Overweight to Equal-Weight and lowers the price target from $64 to $53.
01-15 20:46
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
GitLab, Nutanix receive downgrades to Equal-weight by Morgan Stanley
GitLab (GTLB) and Nutanix (NTNX) were both downgraded to Equal-weight from Overweight by Morgan Stanley. Shares of both were down 2% and 1%, respectively, during Monday morning market action. Morgan S...
01-12 22:51
Nutanix to Present at Upcoming Investor Conference
Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, announced that its management will present at the 28th Annual Needham Growth Conference on January 16, 2026, at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time). A live webcast and replay will be available on Nutanix's Investor Relations website at ir.nutanix.com. Nutanix provides a unified software platform for running applications, AI, and managing data across hybrid multicl...
01-09 13:30
美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
RBC Capital Maintains Outperform on Nutanix, Lowers Price Target to $65
RBC Capital analyst Matthew Hedberg maintains Nutanix (NASDAQ:NTNX) with a Outperform and lowers the price target from $74 to $65.
01-06 00:12
Nutanix launches $300M accelerated share repurchase program
Nutanix (NTNX) entered into a $300M accelerated share repurchase agreement with Bank of America under its existing buyback authorization. The company will fund the ASR using cash on hand, reflecting c...
2025-12-17 23:58
